Brian Cicali

Population PK/PD Modeling Analysis of Lomitapide to Evaluate Gastrointestinal Adverse Events

A Pooled Population Analysis to Evaluate the Efficacy and Safety of Lomitapide in Patients with Homozygous Familial Hypercholesterolaemia (HoFH) on Stable Lipid lowering Therapy

Physiologically-based Pharmacokinetic (PBPK) Modeling of Drug-drug interactions (DDI) for TEV-56268

A Phase III, Single-arm, Open-label, International, Multi-centre Study to Evaluate the Efficacy and Safety of Lomitapide in Paediatric Patients with Homozygous Familial Hypercholesterolaemia (HoFH) on Stable Lipid-lowering Therapy

Characterizing efficacy and safety of hormonal contraceptives by combining pharmacometrics and RWE